The Year Of The Tiger Looking Strong For IPOs In China Following Sinopharm Success

HONG KONG - Concerns over valuation seem to be doing little to dampen enthusiasm for new Chinese pharmaceutical related stocks and the result is a minefield of opportunities on very shaky ground